Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vignesh T Packiam

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
Cancers|January 8, 2025
Sequential Endoluminal Doxorubicin and Gemcitabine Alternating Weekly with Sequential Mitomycin and Docetaxel for Recurrent Non-Muscle Invasive Urothelial CarcinomaIan M McElree, Vignesh T Packiam, Ryan L Steinberg, et al.
BJU International|March 21, 2025
Assessing the efficacy and safety of sequential intravesical gemcitabine and docetaxel - does time from transurethral resection of bladder tumour to induction matter?Ian M McElree, Grant M Henning, Ryan L Steinberg, et al.
The Journal of Urology|July 13, 2022
Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of Non-Muscle-Invasive Bladder CancerIan M McElree, Vignesh T Packiam, Ryan L Steinberg, et al.
Urologic Oncology|May 25, 2025
Bladder-sparing management for high grade noninvasive urothelial carcinoma of the prostateAlexander C Martin, Ian M McElree, Sarah L Mott, et al.
The Journal of Urology|August 30, 2016
Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous HeparinJoseph J Pariser, Shane M Pearce, Blake B Anderson, et al.
Urologic Oncology|November 18, 2018
The role of inguinal lymph node dissection in men with urethral squamous cell carcinomaRyan P Werntz, Christopher B Riedinger, Richard J Fantus, et al.
Translational Cancer Research|December 19, 2024
Bladder sparing management for muscle-invasive bladder cancer after a complete clinical response: ready for prime time?-a narrative reviewMann Patel, Kyle Moore, Benjamin L Lichtbroun, et al.
Cancers|July 27, 2024
Sequential Endoluminal Gemcitabine and Cabazitaxel with Intravenous Pembrolizumab as a Bladder-Preserving Strategy for Docetaxel-Unresponsive Non-Muscle Invasive Urothelial Carcinoma Following Transurethral Resection of Bladder TumorIan M McElree, Vignesh T Packiam, Ryan L Steinberg, et al.
Urologic Oncology|November 10, 2016
Lessons from 151 ureteral reimplantations for postcystectomy ureteroenteric strictures: A single-center experience over a decadeVignesh T Packiam, Vijay A Agrawal, Andrew J Cohen, et al.
World Journal of Urology|August 1, 2016
Redefining the implications of nasogastric tube placement following radical cystectomy in the alvimopan eraVignesh T Packiam, Vijay A Agrawal, Joseph J Pariser, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Cancers|January 8, 2025
Sequential Endoluminal Doxorubicin and Gemcitabine Alternating Weekly with Sequential Mitomycin and Docetaxel for Recurrent Non-Muscle Invasive Urothelial CarcinomaIan M McElree, Vignesh T Packiam, Ryan L Steinberg, et al.
BJU International|March 21, 2025
Assessing the efficacy and safety of sequential intravesical gemcitabine and docetaxel - does time from transurethral resection of bladder tumour to induction matter?Ian M McElree, Grant M Henning, Ryan L Steinberg, et al.
The Journal of Urology|July 13, 2022
Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of Non-Muscle-Invasive Bladder CancerIan M McElree, Vignesh T Packiam, Ryan L Steinberg, et al.
Urologic Oncology|May 25, 2025
Bladder-sparing management for high grade noninvasive urothelial carcinoma of the prostateAlexander C Martin, Ian M McElree, Sarah L Mott, et al.
The Journal of Urology|August 30, 2016
Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous HeparinJoseph J Pariser, Shane M Pearce, Blake B Anderson, et al.
Urologic Oncology|November 18, 2018
The role of inguinal lymph node dissection in men with urethral squamous cell carcinomaRyan P Werntz, Christopher B Riedinger, Richard J Fantus, et al.
Translational Cancer Research|December 19, 2024
Bladder sparing management for muscle-invasive bladder cancer after a complete clinical response: ready for prime time?-a narrative reviewMann Patel, Kyle Moore, Benjamin L Lichtbroun, et al.
Cancers|July 27, 2024
Sequential Endoluminal Gemcitabine and Cabazitaxel with Intravenous Pembrolizumab as a Bladder-Preserving Strategy for Docetaxel-Unresponsive Non-Muscle Invasive Urothelial Carcinoma Following Transurethral Resection of Bladder TumorIan M McElree, Vignesh T Packiam, Ryan L Steinberg, et al.
Urologic Oncology|November 10, 2016
Lessons from 151 ureteral reimplantations for postcystectomy ureteroenteric strictures: A single-center experience over a decadeVignesh T Packiam, Vijay A Agrawal, Andrew J Cohen, et al.
World Journal of Urology|August 1, 2016
Redefining the implications of nasogastric tube placement following radical cystectomy in the alvimopan eraVignesh T Packiam, Vijay A Agrawal, Joseph J Pariser, et al.
Pageof 14